Get the Stockscreener App
179.33
0.90%
-1.63
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $179.33, with a volume of 1.40M.
It is down -0.90% in the last 24 hours and down -0.10% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$180.96
Open:
$179.94
24h Volume:
1.40M
Relative Volume:
1.47
Market Cap:
$20.05B
Revenue:
$9.54B
Net Income/Loss:
$841.00M
P/E Ratio:
24.10
EPS:
7.44
Net Cash Flow:
$1.02B
1W Performance:
-5.11%
1M Performance:
-0.10%
6M Performance:
+5.10%
1Y Performance:
+17.88%
1-Day Range:
$178.25
$180.68
1-Week Range:
$177.79
$191.49
52-Week Range:
$146.17
$191.49
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
179.33 | 20.24B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance
What to expect from Quest Diagnostics Incorporated in the next 30 days2025 Performance Recap & Real-Time Buy Signal Alerts - newser.com
How Quest Diagnostics Incorporated (QDI) stock moves in volatile trading sessionsJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Technical analysis overview for Quest Diagnostics Incorporated stockMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
How Quest Diagnostics Incorporated (QDI) stock responds to job market shiftsJuly 2025 Decliners & Weekly Top Gainers Alerts - newser.com
Analyzing Quest Diagnostics Incorporated with multi timeframe chartsPortfolio Growth Summary & Community Verified Trade Signals - newser.com
How Quest Diagnostics Incorporated (QDI) stock reacts to stronger dollar2025 Geopolitical Influence & Weekly High Momentum Picks - newser.com
Why Quest Diagnostics Incorporated stock could rally strongly2025 Buyback Activity & Daily Profit Focused Screening - newser.com
How Quest Diagnostics Incorporated (QDI) stock behaves in tightening cyclesTrade Signal Summary & Technical Pattern Based Signals - newser.com
Quest Diagnostics Incorporated stock daily chart insightsWeekly Loss Report & Weekly High Return Forecasts - newser.com
Can Quest Diagnostics Incorporated stock sustain breakout momentum2025 Top Gainers & High Yield Stock Recommendations - newser.com
Evaluating Quest Diagnostics Incorporated with trendline analysisExit Point & AI Driven Stock Movement Reports - newser.com
Is Quest Diagnostics Incorporated (QDI) stock a top pick for value investorsMarket Volume Summary & Fast Exit/Entry Strategy Plans - newser.com
Will Quest Diagnostics Incorporated stock hit analyst forecasts2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Will Quest Diagnostics Incorporated continue its uptrend2025 Market Sentiment & Daily Market Momentum Tracking - newser.com
Barclays Maintains Quest Diagnostics (DGX) Equal-Weight Recommendation - Nasdaq
Quest Diagnostics Hits New 52-Week High of $189.23, Reflecting Strong Performance - Markets Mojo
Barclays Raises Price Target for Quest Diagnostics (DGX) to $190 | DGX Stock News - GuruFocus
Barclays Adjusts Price Target on Quest Diagnostics to $190 From $185, Maintains Equalweight Rating - MarketScreener
Quest Diagnostics Hits New 52-Week High at $191.45, Surges 34.71% - Markets Mojo
Pack Health closing in Birmingham, nearly 100 people to be laid off - CBS 42
Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing - Yahoo Finance
Ex-Dividend Reminder: Quest Diagnostics, Bristol Myers Squibb and Globe Life - Nasdaq
Can Quest Diagnostics Incorporated (QDI) stock retain market dominancePrice Action & Risk Managed Investment Signals - newser.com
350,000 Members Waitlisted: WHOOP's New Blood Testing Platform Combines Lab Work with 24/7 Wearable Data - Stock Titan
G&S Capital LLC Invests $1.26 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (NYSE:DGX) Hits New 1-Year HighWhat's Next? - MarketBeat
Washington Capital Management Inc. Sells 2,550 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Capital Insight Partners LLC Invests $359,000 in Quest Diagnostics Incorporated $DGX - MarketBeat
What macro factors could drive Quest Diagnostics Incorporated stock higherTrade Risk Assessment & Weekly High Momentum Picks - newser.com
Wealth Enhancement Advisory Services LLC Sells 17,246 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
How Quest Diagnostics’ 25% Rally and AI Push Are Shaping Its 2025 Valuation - Yahoo Finance
3,163 Shares in Quest Diagnostics Incorporated $DGX Purchased by First American Bank - MarketBeat
Public Employees Retirement System of Ohio Sells 4,384 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Sowell Financial Services LLC Buys Shares of 2,504 Quest Diagnostics Incorporated $DGX - MarketBeat
CX Institutional Reduces Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (NYSE:DGX) SVP Sells $5,293,250.56 in Stock - MarketBeat
Is Quest Diagnostics Stock Underperforming the Dow? - MSN
Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 - Nasdaq
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant - Yahoo Finance
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.01%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):